Cargando…
Autoimmune Disease in Patients With Advanced Thymic Epithelial Tumors
INTRODUCTION: Paraneoplastic autoimmune diseases (ADs) are a hallmark of thymic epithelial tumors (TETs) and affect treatment management in patients with advanced-stage tumors, yet the risk factors for development of AD in advanced TET remain poorly understood. METHODS: All patients with advanced TE...
Autores principales: | Singhal, Surbhi, Hellyer, Jessica, Ouseph, Madhu M., Wakelee, Heather A., Padda, Sukhmani K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121321/ https://www.ncbi.nlm.nih.gov/pubmed/35601925 http://dx.doi.org/10.1016/j.jtocrr.2022.100323 |
Ejemplares similares
-
Genomic clustering analysis identifies molecular subtypes of thymic epithelial tumors independent of World Health Organization histologic type
por: Padda, Sukhmani K., et al.
Publicado: (2021) -
The role of induction therapy for thymic malignancies: a narrative review
por: Patel, Deven C., et al.
Publicado: (2020) -
A phase I dose-escalation and pharmacokinetic study of enzastaurin and erlotinib in patients with advanced solid tumors
por: Padda, Sukhmani K., et al.
Publicado: (2011) -
Genomic characterization of thymic epithelial tumors in a real-world dataset
por: Kurokawa, K., et al.
Publicado: (2023) -
Novel Treatments for Thymoma and Thymic Carcinoma
por: Rajan, Arun, et al.
Publicado: (2015)